PETER S GARCIA Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PETER S GARCIA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER S GARCIA. PETER S GARCIA is a Vice President, CFO in PDL BIOPHARMA, INC. ($PDLI) and a Senior V.P. and C.F.O. in ARCA biopharma, Inc. ($ABIO) and a Chief Financial Officer in ALX ONCOLOGY HOLDINGS INC ($ALXO).
Address: NUVELO, INC. 675 ALMANOR AVENUE SUNNYVALE 94085 CA
Companies in which PETER S GARCIA is an Insider
ALX ONCOLOGY HOLDINGS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER S GARCIA: Chief Financial Officer
Holdings: 3,000 shares
Latest Transaction: Jul 21 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARCA biopharma, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of PETER S GARCIA: Senior V.P. and C.F.O.
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 01 2004
$ABIO Market Capitalization: $23.40M
$ABIO Previous Close: $2.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PDL BIOPHARMA, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of PETER S GARCIA: Vice President, CFO
Holdings: 451,471 shares
Current Value: $997,751
Latest Transaction: Apr 01 2019
$PDLI Market Capitalization: $367.50M
$PDLI Previous Close: $2.21
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PETER S GARCIA
Sentiment: All, ALXO, ABIO, PDLI
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 21 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GARCIA PETER S | Chief Financial Off ... | Buy | P | 19.00 | 3,000 | 57,000 | 3,000 | 0 to 3 K |
| Jul 17 2020 | ALXO | ALX ONCOLOGY HOLDI ... | GARCIA PETER S | Chief Financial Off ... | Option Exercise | A | 19.00 | 88,137 | 1,674,603 | 88,137 | |
| Apr 01 2019 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Option Exercise | A | 3.72 | 628,930 | 2,339,620 | 628,930 | |
| Dec 28 2018 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Sell | D | 0.00 | 226,442 | 0 | 225,029 | 451.5 K to 225 K (-50.16 %) |
| Dec 28 2018 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Payment of Exercise | F | 3.02 | 3,553 | 10,730 | 451,471 | 455 K to 451.5 K (-0.78 %) |
| Sep 27 2018 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Option Exercise | A | 2.52 | 339,678 | 855,989 | 339,678 | |
| Jun 12 2018 | PDLI | PDL BIOPHARMA, INC ... | GARCIA PETER S | Vice President, CFO | Option Exercise | A | 2.94 | 694,900 | 2,043,006 | 694,900 |